NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
0.384
-0.001 (-0.31%)
At close: Feb 21, 2025, 4:00 PM
0.376
-0.008 (-2.03%)
After-hours: Feb 21, 2025, 6:52 PM EST
NanoVibronix Employees
As of December 31, 2023, NanoVibronix had 16 total employees, including 10 full-time and 6 part-time employees. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
$205,688
Profits / Employee
-$192,938
Market Cap
2.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
NAOV News
- 8 days ago - NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - Business Wire
- 6 weeks ago - NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes - Business Wire
- 6 weeks ago - NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan - Business Wire
- 2 months ago - NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Business Wire
- 3 months ago - NanoVibronix Provides Business Update - Business Wire
- 4 months ago - NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - Business Wire
- 5 months ago - NanoVibronix Signs Letter of Intent with Potential New Distributor - Business Wire
- 6 months ago - NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - Business Wire